| 1 | [SID103198031] | Active | IC50 | 0.00706 | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) [AID625192, Type: other] | 5-hydroxytryptamine receptor 2A [gi:543727] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.00706 [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) | | AID | 625192 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 2A [gi:543727] | | PubMed | | | Data Table |  |
|
| 2 | [SID103198031] | Active | IC50 | 0.00706 | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) [AID625192, Type: other] | 5-hydroxytryptamine receptor 2A [gi:543727] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.00706 [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) | | AID | 625192 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 2A [gi:543727] | | PubMed | | | Data Table |  |
|
| 3 | [SID103198031] | Active | IC50 | 0.00706 | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) [AID625192, Type: other] | 5-hydroxytryptamine receptor 2A [gi:543727] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.00706 [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) | | AID | 625192 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 2A [gi:543727] | | PubMed | | | Data Table |  |
|
| 4 | [SID103198031] | Active | IC50 | 0.01 | DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) [AID625202, Type: other] | Alpha-2B adrenergic receptor [gi:27151763] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.01 [uM] | | BioAssay | DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) | | AID | 625202 | | BioAssay type | other | | Target | Alpha-2B adrenergic receptor [gi:27151763] | | PubMed | | | Data Table |  |
|
| 5 | [SID103198031] | Active | IC50 | 0.01 | DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) [AID625202, Type: other] | Alpha-2B adrenergic receptor [gi:27151763] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.01 [uM] | | BioAssay | DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) | | AID | 625202 | | BioAssay type | other | | Target | Alpha-2B adrenergic receptor [gi:27151763] | | PubMed | | | Data Table |  |
|
| 6 | [SID103198031] | Active | IC50 | 0.011 | DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) [AID625253, Type: other] | D(2) dopamine receptor [gi:118206] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.011 [uM] | | BioAssay | DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) | | AID | 625253 | | BioAssay type | other | | Target | D(2) dopamine receptor [gi:118206] | | PubMed | | | Data Table |  |
|
| 7 | [SID103198031] | Active | IC50 | 0.011 | DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) [AID625253, Type: other] | D(2) dopamine receptor [gi:118206] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.011 [uM] | | BioAssay | DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) | | AID | 625253 | | BioAssay type | other | | Target | D(2) dopamine receptor [gi:118206] | | PubMed | | | Data Table |  |
|
| 8 | [SID103198031] | Active | IC50 | 0.011 | DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) [AID625253, Type: other] | D(2) dopamine receptor [gi:118206] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.011 [uM] | | BioAssay | DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) | | AID | 625253 | | BioAssay type | other | | Target | D(2) dopamine receptor [gi:118206] | | PubMed | | | Data Table |  |
|
| 9 | [SID103198031] | Active | IC50 | 0.011 | DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) [AID625253, Type: other] | D(2) dopamine receptor [gi:118206] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.011 [uM] | | BioAssay | DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) | | AID | 625253 | | BioAssay type | other | | Target | D(2) dopamine receptor [gi:118206] | | PubMed | | | Data Table |  |
|
| 10 | [SID103198031] | Active | IC50 | 0.011 | DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) [AID625253, Type: other] | D(2) dopamine receptor [gi:118206] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.011 [uM] | | BioAssay | DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) | | AID | 625253 | | BioAssay type | other | | Target | D(2) dopamine receptor [gi:118206] | | PubMed | | | Data Table |  |
|
| 11 | [SID103198031] | Active | IC50 | 0.013 | DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) [AID625254, Type: other] | D(3) dopamine receptor [gi:1169206] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.013 [uM] | | BioAssay | DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) | | AID | 625254 | | BioAssay type | other | | Target | D(3) dopamine receptor [gi:1169206] | | PubMed | | | Data Table |  |
|
| 12 | [SID103198031] | Active | IC50 | 0.013 | DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) [AID625254, Type: other] | D(3) dopamine receptor [gi:1169206] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.013 [uM] | | BioAssay | DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) | | AID | 625254 | | BioAssay type | other | | Target | D(3) dopamine receptor [gi:1169206] | | PubMed | | | Data Table |  |
|
| 13 | [SID103198031] | Active | IC50 | 0.013 | DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) [AID625254, Type: other] | D(3) dopamine receptor [gi:1169206] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.013 [uM] | | BioAssay | DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) | | AID | 625254 | | BioAssay type | other | | Target | D(3) dopamine receptor [gi:1169206] | | PubMed | | | Data Table |  |
|
| 14 | [SID103198031] | Active | IC50 | 0.013 | DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) [AID625254, Type: other] | D(3) dopamine receptor [gi:1169206] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.013 [uM] | | BioAssay | DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) | | AID | 625254 | | BioAssay type | other | | Target | D(3) dopamine receptor [gi:1169206] | | PubMed | | | Data Table |  |
|
| 15 | [SID103198031] | Active | IC50 | 0.024 | DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine) [AID625269, Type: other] | Histamine H1 receptor [gi:547645] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.024 [uM] | | BioAssay | DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine) | | AID | 625269 | | BioAssay type | other | | Target | Histamine H1 receptor [gi:547645] | | PubMed | | | Data Table |  |
|
| 16 | [SID103198031] | Active | IC50 | 0.024 | DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine) [AID625269, Type: other] | Histamine H1 receptor [gi:547645] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.024 [uM] | | BioAssay | DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine) | | AID | 625269 | | BioAssay type | other | | Target | Histamine H1 receptor [gi:547645] | | PubMed | | | Data Table |  |
|
| 17 | [SID103198031] | Active | IC50 | 0.032 | DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) [AID625198, Type: other] | Alpha-1D adrenergic receptor [gi:1168244] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.032 [uM] | | BioAssay | DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) | | AID | 625198 | | BioAssay type | other | | Target | Alpha-1D adrenergic receptor [gi:1168244] | | PubMed | | | Data Table |  |
|
| 18 | [SID103198031] | Active | IC50 | 0.034 | DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) [AID625200, Type: other] | Alpha-1D adrenergic receptor [gi:1168243] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.034 [uM] | | BioAssay | DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) | | AID | 625200 | | BioAssay type | other | | Target | Alpha-1D adrenergic receptor [gi:1168243] | | PubMed | | | Data Table |  |
|
| 19 | [SID103198031] | Active | IC50 | 0.034 | DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) [AID625200, Type: other] | Alpha-1D adrenergic receptor [gi:1168243] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.034 [uM] | | BioAssay | DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) | | AID | 625200 | | BioAssay type | other | | Target | Alpha-1D adrenergic receptor [gi:1168243] | | PubMed | | | Data Table |  |
|
| 20 | [SID103198031] | Active | IC50 | 0.034 | DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) [AID625200, Type: other] | Alpha-1D adrenergic receptor [gi:1168243] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.034 [uM] | | BioAssay | DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) | | AID | 625200 | | BioAssay type | other | | Target | Alpha-1D adrenergic receptor [gi:1168243] | | PubMed | | | Data Table |  |
|
| 21 | [SID103198031] | Active | IC50 | 0.054 | DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) [AID625223, Type: other] | Sigma non-opioid intracellular receptor 1 [gi:74752153] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.054 [uM] | | BioAssay | DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) | | AID | 625223 | | BioAssay type | other | | Target | Sigma non-opioid intracellular receptor 1 [gi:74752153] | | PubMed | | | Data Table |  |
|
| 22 | [SID103198031] | Active | IC50 | 0.054 | DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) [AID625223, Type: other] | Sigma non-opioid intracellular receptor 1 [gi:74752153] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.054 [uM] | | BioAssay | DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) | | AID | 625223 | | BioAssay type | other | | Target | Sigma non-opioid intracellular receptor 1 [gi:74752153] | | PubMed | | | Data Table |  |
|
| 23 | [SID103198031] | Active | IC50 | 0.078 | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) [AID625218, Type: other] | 5-hydroxytryptamine receptor 2C [gi:112816] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.078 [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) | | AID | 625218 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 2C [gi:112816] | | PubMed | | | Data Table |  |
|
| 24 | [SID103198031] | Active | IC50 | 0.078 | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) [AID625218, Type: other] | 5-hydroxytryptamine receptor 2C [gi:112816] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.078 [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) | | AID | 625218 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 2C [gi:112816] | | PubMed | | | Data Table |  |
|
| 25 | [SID103198031] | Active | IC50 | 0.078 | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) [AID625218, Type: other] | 5-hydroxytryptamine receptor 2C [gi:112816] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.078 [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) | | AID | 625218 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 2C [gi:112816] | | PubMed | | | Data Table |  |
|
| 26 | [SID103198031] | Active | IC50 | 0.082 | DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) [AID625203, Type: other] | Alpha-2C adrenergic receptor [gi:20141211] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.082 [uM] | | BioAssay | DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) | | AID | 625203 | | BioAssay type | other | | Target | Alpha-2C adrenergic receptor [gi:20141211] | | PubMed | | | Data Table |  |
|
| 27 | [SID103198031] | Active | IC50 | 0.082 | DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) [AID625203, Type: other] | Alpha-2C adrenergic receptor [gi:20141211] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.082 [uM] | | BioAssay | DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) | | AID | 625203 | | BioAssay type | other | | Target | Alpha-2C adrenergic receptor [gi:20141211] | | PubMed | | | Data Table |  |
|
| 28 | [SID103198031] | Active | IC50 | 0.089 | DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) [AID625199, Type: other] | Alpha-1B adrenergic receptor [gi:543734] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.089 [uM] | | BioAssay | DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) | | AID | 625199 | | BioAssay type | other | | Target | Alpha-1B adrenergic receptor [gi:543734] | | PubMed | | | Data Table |  |
|
| 29 | [SID103198031] | Active | IC50 | 0.089 | DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) [AID625199, Type: other] | Alpha-1B adrenergic receptor [gi:543734] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.089 [uM] | | BioAssay | DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) | | AID | 625199 | | BioAssay type | other | | Target | Alpha-1B adrenergic receptor [gi:543734] | | PubMed | | | Data Table |  |
|
| 30 | [SID103198031] | Active | IC50 | 0.102 | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) [AID625217, Type: other] | 5-hydroxytryptamine receptor 2B [gi:1168220] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.102 [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) | | AID | 625217 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 2B [gi:1168220] | | PubMed | | | Data Table |  |
|
| 31 | [SID103198031] | Active | IC50 | 0.102 | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) [AID625217, Type: other] | 5-hydroxytryptamine receptor 2B [gi:1168220] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.102 [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) | | AID | 625217 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 2B [gi:1168220] | | PubMed | | | Data Table |  |
|
| 32 | [SID103198031] | Active | IC50 | 0.102 | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) [AID625217, Type: other] | 5-hydroxytryptamine receptor 2B [gi:1168220] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.102 [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) | | AID | 625217 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 2B [gi:1168220] | | PubMed | | | Data Table |  |
|
| 33 | [SID103198031] | Active | IC50 | 0.155 | DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390) [AID625252, Type: other] | D(1A) dopamine receptor [gi:118228] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.155 [uM] | | BioAssay | DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390) | | AID | 625252 | | BioAssay type | other | | Target | D(1A) dopamine receptor [gi:118228] | | PubMed | | | Data Table |  |
|
| 34 | [SID103198031] | Active | IC50 | 0.155 | DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390) [AID625252, Type: other] | D(1A) dopamine receptor [gi:118228] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.155 [uM] | | BioAssay | DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390) | | AID | 625252 | | BioAssay type | other | | Target | D(1A) dopamine receptor [gi:118228] | | PubMed | | | Data Table |  |
|
| 35 | [SID103198031] | Active | IC50 | 0.155 | DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390) [AID625252, Type: other] | D(1A) dopamine receptor [gi:118228] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.155 [uM] | | BioAssay | DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390) | | AID | 625252 | | BioAssay type | other | | Target | D(1A) dopamine receptor [gi:118228] | | PubMed | | | Data Table |  |
|
| 36 | [SID103198031] | Active | IC50 | 0.155 | DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390) [AID625252, Type: other] | D(1A) dopamine receptor [gi:118228] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.155 [uM] | | BioAssay | DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390) | | AID | 625252 | | BioAssay type | other | | Target | D(1A) dopamine receptor [gi:118228] | | PubMed | | | Data Table |  |
|
| 37 | [SID103198031] | Active | IC50 | 0.169 | DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) [AID625201, Type: other] | Alpha-2A adrenergic receptor [gi:1351829] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.169 [uM] | | BioAssay | DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) | | AID | 625201 | | BioAssay type | other | | Target | Alpha-2A adrenergic receptor [gi:1351829] | | PubMed | | | Data Table |  |
|
| 38 | [SID103198031] | Active | IC50 | 0.169 | DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) [AID625201, Type: other] | Alpha-2A adrenergic receptor [gi:1351829] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.169 [uM] | | BioAssay | DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) | | AID | 625201 | | BioAssay type | other | | Target | Alpha-2A adrenergic receptor [gi:1351829] | | PubMed | | | Data Table |  |
|
| 39 | [SID103198031] | Active | IC50 | 0.22 | DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625155, Type: other] | Muscarinic acetylcholine receptor M [gi:543761] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.22 [uM] | | BioAssay | DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625155 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:543761] | | PubMed | | | Data Table |  |
|
| 40 | [SID103198031] | Active | IC50 | 0.22 | DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625155, Type: other] | Muscarinic acetylcholine receptor M [gi:543761] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.22 [uM] | | BioAssay | DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625155 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:543761] | | PubMed | | | Data Table |  |
|
| 41 | [SID103198031] | Active | IC50 | 0.22 | DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625155, Type: other] | Muscarinic acetylcholine receptor M [gi:543761] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.22 [uM] | | BioAssay | DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625155 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:543761] | | PubMed | | | Data Table |  |
|
| 42 | [SID103198031] | Active | IC50 | 0.22 | DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625155, Type: other] | Muscarinic acetylcholine receptor M [gi:543761] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.22 [uM] | | BioAssay | DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625155 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:543761] | | PubMed | | | Data Table |  |
|
| 43 | [SID103198031] | Active | IC50 | 0.267 | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide) [AID625221, Type: other] | 5-hydroxytryptamine receptor 6 [gi:1703010] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.267 [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide) | | AID | 625221 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 6 [gi:1703010] | | PubMed | | | Data Table |  |
|
| 44 | [SID103198031] | Active | IC50 | 0.267 | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide) [AID625221, Type: other] | 5-hydroxytryptamine receptor 6 [gi:1703010] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.267 [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide) | | AID | 625221 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 6 [gi:1703010] | | PubMed | | | Data Table |  |
|
| 45 | [SID103198031] | Active | IC50 | 0.267 | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide) [AID625221, Type: other] | 5-hydroxytryptamine receptor 6 [gi:1703010] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.267 [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide) | | AID | 625221 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 6 [gi:1703010] | | PubMed | | | Data Table |  |
|
| 46 | [SID103198031] | Active | IC50 | 0.3 | DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) [AID625249, Type: other] | Cytochrome P450 2D6 [gi:84028191] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.3 [uM] | | BioAssay | DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) | | AID | 625249 | | BioAssay type | other | | Target | Cytochrome P450 2D6 [gi:84028191] | | PubMed | | | Data Table |  |
|
| 47 | [SID103198031] | Active | IC50 | 0.3 | DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) [AID625249, Type: other] | Cytochrome P450 2D6 [gi:84028191] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.3 [uM] | | BioAssay | DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) | | AID | 625249 | | BioAssay type | other | | Target | Cytochrome P450 2D6 [gi:84028191] | | PubMed | | | Data Table |  |
|
| 48 | [SID11111685] | Active | Potency | 0.3981 | qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2D6 [AID891, Type: confirmatory] | cytochrome P450 2D6 isoform 1 [Homo sapiens] [gi:40805836] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 11111685 | | CID | 4917 | | Outcome | Active | | Potency | 0.3981 [uM] | | BioAssay | qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2D6 | | AID | 891 | | BioAssay type | confirmatory | | Target | cytochrome P450 2D6 isoform 1 [Homo sapiens] [gi:40805836] | | PubMed | | | Data Table |  |
|
| 49 | [SID103198031] | Active | IC50 | 0.4 | DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) [AID625207, Type: other] | Sodium-dependent noradrenaline transporter [gi:128616] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.4 [uM] | | BioAssay | DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) | | AID | 625207 | | BioAssay type | other | | Target | Sodium-dependent noradrenaline transporter [gi:128616] | | PubMed | | | Data Table |  |
|
| 50 | [SID103198031] | Active | IC50 | 0.4 | DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) [AID625207, Type: other] | Sodium-dependent noradrenaline transporter [gi:128616] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 103198031 | | CID | 4917 | | Outcome | Active | | IC50 | 0.4 [uM] | | BioAssay | DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) | | AID | 625207 | | BioAssay type | other | | Target | Sodium-dependent noradrenaline transporter [gi:128616] | | PubMed | | | Data Table |  |
|